These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23573418)

  • 1. Current challenges to the United states' AIDS drug assistance program and possible implications of the affordable care act.
    McManus KA; Engelhard CL; Dillingham R
    AIDS Res Treat; 2013; 2013():350169. PubMed ID: 23573418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AIDS drug assistance programs and coverage of HIV-related medications.
    Smith SR; Buchanan RJ
    Ann Pharmacother; 2001 Feb; 35(2):155-66. PubMed ID: 11215833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chances dim for fiscal '97 boost in AIDS drug funds.
    AIDS Policy Law; 1997 Jun; 12(11):1, 10. PubMed ID: 11364383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009.
    Hanna DB; Buchacz K; Gebo KA; Hessol NA; Horberg MA; Jacobson LP; Kirk GD; Kitahata MM; Korthuis PT; Moore RD; Napravnik S; Patel P; Silverberg MJ; Sterling TR; Willig JH; Collier A; Samji H; Thorne JE; Althoff KN; Martin JN; Rodriguez B; Stuart EA; Gange SJ;
    PLoS One; 2013; 8(11):e78952. PubMed ID: 24260137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ryan White CARE Act Title IV programs: a preliminary characterization of benefits and costs.
    Abramowitz S; Greene D
    AIDS Public Policy J; 2005; 20(3-4):108-25. PubMed ID: 17624034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic benefits of the United States' AIDS drug assistance Program: A systematic review of cost analyses to guide research and policy priorities.
    McManus KA; Strumpf A; Killelea A; Horn T; Hamp A; Keim-Malpass J
    Prev Med Rep; 2022 Oct; 29():101969. PubMed ID: 36161113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affordable Care Act Qualified Health Plan Enrollment for AIDS Drug Assistance Program Clients: Virginia's Experience and Best Practices.
    McManus KA; Rodney RC; Rhodes A; Bailey S; Dillingham R
    AIDS Res Hum Retroviruses; 2016 Sep; 32(9):885-91. PubMed ID: 27346694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPACA and Low-Income People Living with HIV: 2014 Qualified Health Plan Enrollment in a Medicaid Nonexpansion State.
    McManus KA; McGonigle KM; Engelhard CL; Dillingham R
    South Med J; 2016 Jun; 109(6):371-7. PubMed ID: 27255096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAP funding and Ryan White Act renewal is delayed by hurricane. HIV patients from disaster area spread across U.S.
    AIDS Alert; 2005 Oct; 20(10):109, 111-3. PubMed ID: 16276566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State variation in AIDS drug assistance program prescription drug coverage for modifiable cardiovascular risk factors.
    Blackstock OJ; Wang KH; Fiellin DA
    J Gen Intern Med; 2011 Dec; 26(12):1426-33. PubMed ID: 21837376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ryan White HIV/AIDS Program Assistance and HIV Treatment Outcomes.
    Bradley H; Viall AH; Wortley PM; Dempsey A; Hauck H; Skarbinski J
    Clin Infect Dis; 2016 Jan; 62(1):90-98. PubMed ID: 26324390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinton seeks $65 million for States' AIDS drug programs.
    AIDS Policy Law; 1996 Aug; 11(14):3. PubMed ID: 11363679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment successes draining ADAP resources.
    AIDS Alert; 1998 Aug; 13(8):88. PubMed ID: 11365649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS Drug Assistance Programs: managers confront uncertainty and need to adapt as the Affordable Care Act kicks in.
    Martin EG; Meehan T; Schackman BR
    Health Aff (Millwood); 2013 Jun; 32(6):1063-71. PubMed ID: 23733980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Population Affected by the 6-Month Recertification Criterion of the Ryan White HIV/AIDS Program's AIDS Drug Assistance Program in Washington State, 2017-2019.
    Erly S; Khosropour CM; Hajat A; Sharma M; Reuer J; Grimm M; Kwaiser K; Dombrowski JC
    J Acquir Immune Defic Syndr; 2022 Jan; 89(1):27-33. PubMed ID: 34596081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of State AIDS Drug Assistance Policies on Clinical and Economic Outcomes of People With HIV.
    Snider JT; Goldman DP; Rosenblatt L; Seekins D; Juday T; Sanchez Y; Wu Y; Peneva D; Romley JA
    Med Care Res Rev; 2016 Jun; 73(3):329-48. PubMed ID: 26537525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV care providers emphasize the importance of the Ryan White Program for access to and quality of care.
    Sood N; Juday T; Vanderpuye-Orgle J; Rosenblatt L; Romley JA; Peneva D; Goldman DP
    Health Aff (Millwood); 2014 Mar; 33(3):394-400. PubMed ID: 24590936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitators and Barriers: Clients' Perspective on the Virginia AIDS Drug Assistance Program's Affordable Care Act Implementation.
    McManus KA; Debolt C; Elwood S; Saint-Surin T; Winstead-Derlega C; Brennan RO; Dillingham R; Flickinger TE
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):734-745. PubMed ID: 31146536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the need to reform the US AIDS Drug Assistance Program.
    Whigham MR
    J Int Assoc Physicians AIDS Care; 1998 Jan; 4(1):39-40. PubMed ID: 11365032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study underscores need for increased ADAP funding.
    AIDS Policy Law; 1997 Aug; 12(14):6-9. PubMed ID: 11364558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.